𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ammonium chloride metabolic acidosis and the activity of renin-angiotensin-aldosterone system in children

✍ Scribed by Z. S. Györke; E. Sulyok; J. -P. Guignard

Publisher
Springer
Year
1991
Tongue
English
Weight
335 KB
Volume
150
Category
Article
ISSN
0340-6997

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of ADH on the activity and funct
Effects of ADH on the activity and function of the renin-angiotensin-aldosterone system in infants and in children
✍ R. Joppich; P. Weber; U. Kiemann; R. Herbst; E. Friedrich 📂 Article 📅 1976 🏛 Springer 🌐 English ⚖ 400 KB

In babies ranging in age from 1 to 25 weeks and in children between 1 and 14 years, plasma renin activity and urinary aldosterone activity were determined in relation to urinary sodium excretion. A reciprocal correlation was found demonstrating that the hyperactivity of the renin-angiotensin-aldoste

The effect of dopamine administration on
The effect of dopamine administration on the activity of the renin-angiotensin-aldosterone system in sick preterm infants
✍ E. Sulyok; I. Seri; T. Tulassay; J. Kiszel; T. Ertl 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 312 KB

Nine premature infants with birth weight of 1150 to 2500 g and gestational age of 28 to 35 weeks were given dopamine in a dose of 2-4 gg/kg/min to treat cardiopulmonary distress. In addition to monitoring of blood gases, blood pressure, acid-base balance, urine flow and urinary sodium excretion, pl

Clinical consequences of withholding ver
Clinical consequences of withholding versus administering renin-angiotensin-aldosterone system antagonists in the preoperative period
✍ David J. Rosenman; Furman S. McDonald; Jon O. Ebbert; Patricia J. Erwin; Matthew 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB

## Abstract ## BACKGROUND: Hospitalists involved in perioperative care either stop or continue until the day of surgery renin‐angiotensin‐aldosterone system antagonists (either angiotensin‐converting enzyme inhibitors [ACEI] or angiotensin II receptor subtype 1 antagonists [ARA]) in patients who u